This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | MicrobiomeTrials
← Back to trials NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-02-26Est. Completion: 2027-09-01
Enrollment target: 740 participantsLocations City of Hope, Duarte, California, United States Yale Cancer Center, New Haven, Connecticut, United States AdventHealth Medical Group Oncology Research at Celebration, Kissimmee, Florida, United States University of Illinois Cancer Center, Chicago, Illinois, United States Johns Hopkins University, Baltimore, Maryland, United States Maryland Oncology Hematology, PA, Rockville, Maryland, United States Health Partners Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States Health Partners Cancer Center at Regions Hospital, Saint Paul, Minnesota, United States Washington University, School of Medicine, St Louis, Missouri, United States Roswell Park Cancer Institute IDS, Buffalo, New York, United States Memorial Sloan Kettering Hospital, New York, New York, United States SCRI Oncology Partners, Nashville, Tennessee, United States The University of Texas MD Anderson Cancer Center, Houston, Texas, United States Fred Hutchinson Cancer Center, Seattle, Washington, United States Chris O'Brien Lifehouse, Camperdown, Australia Other microbiome trials you might be interested in Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020
Non-small Cell Lung Cancer
Icon Cancer Centre Chermside, Chermside, Australia
Monash Medical Centre Clayton, Clayton, Australia
Icon Cancer Centre Hobart, Hobart, Australia
Icon Cancer Centre Townsville, Hyde Park, Australia
Cliniques Universitaires Saint-Luc, Brussels, Belgium
UZA, Edegem, Belgium
Universitair Ziekenhuis Gent, Ghent, Belgium
Universitair Ziekenhuis Brussel, Jette, Belgium
UZ Leuven, Leuven, Belgium
Cross Cancer Institute, Edmonton, Alberta, Canada
Sunnybrook Research Institute, Toronto, Canada
Princess Margaret Cancer Centre, Toronto, Canada
BC Cancer - Vancouver, Vancouver, Canada
West China Hospital, Sichuan University, Chengdu, China
Sun Yat-sen University Cancer Center, Guangzhou, China
Chu Bordeaux, Bordeaux, France
Centre Georges Franăois Leclerc, Dijon, France
Hopital Claude Huriez - Chu Lille, Lille, France
Centre Léon Bérard, Lyon, France
Hăpital de La Timone, Marseille, France
Chu Nantes - Hătel Dieu, Nantes, France
Institut Claudius Regaud, Toulouse, France
ICL - Alexis Vautrin, Vandœuvre-lès-Nancy, France
Institut Gustave Roussy, Villejuif, France
Krankenhaus Nordwest GmbH, Frankfurt, Germany
Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét, Hungary
Humanitas Gavazzeni, Bergamo, Italy
IRCCS Ospedale Policlinico San Martino, Genova, Italy
AOU Federico II - Oncologia Clinica, Naples, Italy
Centro Ricerche Cliniche di Verona s.r.l., Verona, Italy
Saitama Medical University International Medical Center, Hidaka, Japan
HAKUAIKAI Social Medical Corporation Sagara Hospital, Kagoshima, Japan
Kanagawa Cancer Center, Kanagawa, Japan
National Cancer Center Hospital East, Kashiwa-shi, Japan
NHO Shikoku Cancer Center, Matsuyama, Japan
Shizuoka Cancer Center, Nagaizumi-cho, Japan
Aichi Cancer Center Hospital, Nagoya, Japan
Kindai University Hospital, Osakasayama-shi, Japan
Saitama Cancer Center, Saitama, Japan
National Cancer Center Hospital, Tokyo, Japan
Cancer Institute Hospital of JFCR, Tokyo, Japan
SHOWA Medical University Hospital, Tokyo, Japan
Yokohama City University Medical Center, Yokohama, Japan
Amsterdam UMC locatie Vumc, Amsterdam, Netherlands
Universitair Medisch Centrum Groningen, Groningen, Netherlands
Leids Universitair Medisch Centrum, Leiden, Netherlands
Maastricht University Medical Center, Maastricht, Netherlands
Radboud University Medical Center, Nijmegen, Netherlands
Akershus universitetssykehus, Lørenskog, Norway
Haukeland universitetssjukehus, Lørenskog, Norway
Oslo Universitetssykehus HF, Radiumhospitalet, Oslo, Norway
Kyungpook National University Chilgok Hospital, Daegu, South Korea
National Cancer Center, Gyeonggi-do, South Korea
Cha Bundang Medical Center, Cha University, Seongnam, South Korea
Seoul National University Bundang Hospital, Seongnam, South Korea
Seoul National University Hospital, Seoul, South Korea
Severance Hospital, Yonsei University Health System, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Hospital Universitari Vall D'Hebron, Barcelona, Spain
Hospital Clinic de Barcelona, Barcelona, Spain
Hospital de La Santa Creu I Sant Pau, Barcelona, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Universitario Ramon Y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga, Spain
Hospital Universitario Virgen Macarena, Seville, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Taichung Veterans General Hospital, Taichung, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
MacKay Memorial Hospital, Taipei, Taiwan
Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Chang Gung Memorial Hospital, Taoyuan, Taiwan
Addenbrooke's Hospital, Cambridge, United Kingdom
University Hospital Coventry, Coventry, United Kingdom
Barts Hospital, London, United Kingdom
Royal Free Hospital, London, United Kingdom
Nottingham City Hospital Campus, Nottingham, United Kingdom This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participa…
Bakersfield, United States Est. completion Jan 24, 2028
Malignant Pleural Mesothelioma, Advanced
This Phase 1b/2, open-label, multicenter, single-arm study evaluates the safety and efficacy of ivonescimab in combinati…
Shanghai, China Est. completion Nov 30, 2028